anticancer therapeutics (Johns Hopkins University)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameanticancer therapeutics (Johns Hopkins University)
Drug Alias Name8-quinolinolNSC-24076NSC-125034
ClassificationSmall molecules
Mechanisms of ActionStem cells inhibitorsNuclear factor NF-kappa-B complex inhibitorsChelating agents
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohns Hopkins Technology VenturesJohns Hopkins University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A